Stock Market News1 week Stifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty ahead Investing.com
X2 weeks Private Medicare plans must cover Biogen’s ALS drug, US agency says Investing.com
X2 weeks Biogen Stock Declines 21.4% in 3 Months: How to Play the Stock Zacks
X2 weeks Biogen cut at Jefferies as ‘2025 has a tough setup’ Investing.com
X3 weeks Biogen Inc. (BIIB) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call Transcript Seeking Alpha
X1 month Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe Zacks
X1 month Here’s Why Biogen Inc. (BIIB) is a Strong Value Stock Zacks
X2 months Are Investors Undervaluing Biogen (BIIB) Right Now? Zacks
X2 months Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter Seeking Alpha
X2 months Biogen Beats on Q3 Earnings & Sales, Raises ’24 EPS View Zacks
X2 months Biogen Inc. (BIIB) Q3 2024 Earnings Call Transcript Seeking Alpha
X2 months Biogen lifts annual profit forecast as new treatments boost earnings Investing.com
X2 months Biogen (NASDAQ:BIIB) Releases FY 2024 Earnings Guidance MarketBeat
X2 months Short Interest in Biogen Inc. (NASDAQ:BIIB) Grows By 7.7% MarketBeat
X2 months Biogen raises annual profit forecast as new treatments boost earnings Investing.com
X2 months Biogen Sinks. Why A Surprise Boost From Its Alzheimer’s Drug Wasn’t Enough. Investor's Business Daily
X2 months Alphabet, Biogen, Humana rise premarket; AMD, Eli Lilly fall Investing.com
X2 months Biogen (NASDAQ:BIIB) Sees Unusually-High Trading Volume – Here’s What Happened MarketBeat
X2 months Greenleaf Trust Sells 3,475 Shares of Biogen Inc. (NASDAQ:BIIB) MarketBeat
X2 months Will New Drugs Help Biogen Surpass Q3 Earnings Estimates? Zacks
X2 months International Assets Investment Management LLC Has $695.87 Million Stake in Biogen Inc. (NASDAQ:BIIB) MarketBeat
X2 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen Zacks
X2 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen Zacks
X2 months Biogen Inc. (NASDAQ:BIIB) Shares Bought by Raymond James & Associates MarketBeat
X2 months Arlington Partners LLC Acquires 4,902 Shares of Biogen Inc. (NASDAQ:BIIB) MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.